Navigation Links
The MMRF and John Theurer Cancer Center to host patient symposium

NORWALK, C.T. and HACKENSACK, N.J. (March 16, 2011) The Multiple Myeloma Research Foundation (MMRF) and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium (MMRC), will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm. This free educational program is for patients and caregivers who want to learn more about treatment options for multiple myeloma.

"As a result of the tremendous progress we have made accelerating the development of multiple myeloma treatments, patients are living longer and have more treatment options," said Anne Quinn Young, MPH, Vice President of Communications at the MMRF. "MMRF Clinical Insights programs aim to empower patients and their caregivers by arming them with the knowledge they need to optimally manage their disease. We are proud to join our partners at the John Theurer Cancer Center and other renowned institutions to host this important program."

Leading multiple myeloma experts will highlight the latest information in multiple myeloma diagnosis, treatment options, clinical trials and research. Topics to be discussed include treatment options for newly diagnosed patients, stem cell transplantation, relapsed/refractory disease, clinical trials, supportive care options, and managing bone disease.

"For nearly five years, we have worked closely with the MMRF through the MMRC, a unique research model critical to bringing new treatments to our patients faster," said David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma. "We are excited to take our collaboration with the MMRF outside of the clinic by developing content for this educational symposium, which will be a valuable resource for our patients and their loved ones."

Dr. Siegel and David H. Vesole, M.D., Ph.D., Co-Chief, Multiple Myeloma, John Theurer Cancer Center are serving as the official program co-chairs for this patient symposium. Additional presenters include:

  • Jonathan Kaufman, M.D., Assistant Professor, Blood & Marrow Transplantation, Emory University School of Medicine
  • Ann McNeill, RN, MSN, APN, Advanced Practice Nurse, Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center
  • Nikhil C. Munshi, M.D., Associate Director, Jerome Lipper Multiple Myeloma Center, Dana- Farber Cancer Institute
  • G. David Roodman, M.D., Ph.D., Professor of Medicine and Vice Chair for Research, University of Pittsburgh School of Medicine

Following the symposium, attendees will also have the opportunity to participate in special workshop sessions with Dr. Siegel, Dr. Vesole and Ms. McNeill of the John Theurer Cancer Center. Workshop session topics include Multiple Myeloma 101, Maintenance Therapy and Interpreting Test Results.

"With so much exciting research and treatment options emerging, multiple myeloma patients and caregivers often feel overwhelmed," said Dr. Vesole. "It is our responsibility to keep the multiple myeloma community informed of our progress and how it will impact the management of their disease."

The symposium will be hosted at the Hilton Short Hills, 41 JFK Parkway, Short Hills, NJ on Saturday, April 2 from 9:00am-3:30pm. This program is free, however, space is limited. Online registration is available at For additional information, special accommodations or meal requests please contact Sara Tyghter at 203.652.0219 or


Contact: Jaymie DeGaetano
John Theurer Cancer Center

Related medicine news :

1. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
2. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
3. Oncology basic research director at John Theurer Cancer Center continues transplantation research
4. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
5. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
6. John Theurer Cancer Center to present innovative research at 2 surgical meetings
7. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
8. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
9. The John Theurer Cancer Center recognizes medical physics team for safety track record
10. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
11. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology: